Tech and Medicine Must Evolve Together – CES 2020
The American College of Cardiology’s chief innovation officer discusses why the technology industry and health care industry must come together to champion the future of digital health.
Related Articles
Navigating the New “Signaling” Component in CV Fellowship Applications – American College of Cardiology
Understand and strategically utilize the new program signaling feature for the 2026 Cardiovascular Fellowship MyERAS ® application season. Join ACC’s Program Directors and Graduate Medical…
ACC Quality Summit – NCDR and Accreditation Annual Session & Expo
Abstracts are now open! Want to take your abstract a step further: Turn your Quality Summit abstract into a published case report! Join Mary Norine…
TANDEM and BROADWAY: Investigating the Safety and Efficacy of Obicetrapib – American College of Cardiology
A fixed-dose combination therapy of obicetrapib plus ezetimibe was found to significantly reduce LDL-C in patients with preexisting or at high risk for developing atherosclerotic…
Call for Nominations for Vice President and Trustees – American College of Cardiology
Nominations are due by June 23, 2023. Submit your nominations today!
Call For Applications | US Vice Chair, ACC Latin America – American College of Cardiology
Call For Applications | US Vice Chair, ACC Latin America
ICARO: IVUS Assessment Feasible and Safe For Patients After TAVR – American College of Cardiology
The use of IVUS to assess the coronary ostia at high risk for coronary artery obstruction (CAO) after TAVR is feasible, safe and potentially lifesaving,…
From Collapse to Clarity: Diagnosing a Teenager’s Unexplained Syncope – American College of Cardiology
A previously healthy 13-year-old girl presents to the emergency department (ED) after an episode of syncope. Her older sister reported that, after sitting up in…
Wael Al Mahmeed Dedication to Young Leaders – American College of Cardiology
The Wael Al Mahmeed Dedication to Young Leaders program was created to train and support the next generation of cardiovascular leaders internationally.
DOACs vs. Warfarin After TAVR: Insights From the STS/ACC TVT Registry – American College of Cardiology
Use of direct oral anticoagulants (DOACs) as opposed to warfarin after TAVR exhibited a lower risk of bleeding requiring hospitalization, all-cause mortality and stroke at…